{"entity":{"id":"nct01373515","kind":"trial","name":"Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia","aka":[],"tldr":"A phase 1/2 trial of Vididencel run by Mendus, completed.","summary":"Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia is a phase 1/2 interventional study registered as NCT01373515 by Mendus, with 12 participants enrolled, started 2011-04. Conditions recorded: Acute Myeloid Leukemia (AML) and Leukemic Dendritic Cell Vaccination. Interventions recorded: DCP-001.","status":"completed","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT01373515","url":"https://clinicaltrials.gov/study/NCT01373515"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["aml"],"sections":[],"technologies":[],"targets":[],"drugs":["vididencel"],"companies":["mendus"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT01373515","phase":"1/2","setting":"Phase 1 Study of Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia","sponsor":"Mendus","enrolled":12,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct01373515/","neighbours":{"cancer":[{"id":"aml","kind":"cancer","name":"Acute myeloid leukaemia","route":"/cancers/aml/"}],"drug":[{"id":"vididencel","kind":"drug","name":"Vididencel","route":"/drugs/vididencel/"}],"company":[{"id":"mendus","kind":"company","name":"Mendus","route":"/companies/mendus/"}]}}